Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Feb 09, 2022 1:29pm
143 Views
Post# 34413314

RE:Would someone pay $ 2B for DIMI?

RE:Would someone pay $ 2B for DIMI?DaVita would really benifit from Baxter's manufacturing, distribution and sales.. while Baxter would love DaVita's address book and relationships with about 1/2 the dialysis patients in the US.


Also CVS posted huge earnings today. Based on vaccines brought shoppers back into their stores..
1. Need to bring people back into stores now that more people are getting their meds online. 
2. Need to cut massive kidney care costs for their 69Billion Aetna insurance arm.
3. Need new revenue streams.
4. Store square footage going to waste- ours still has a photo dept.- Ha.
5. Not a single mention of Deka (the machine they tried to get approved for home and clinic use) on their conference call.

Easy math.  Let's get it done.
<< Previous
Bullboard Posts
Next >>